Stem Cell Research & Therapy · 2019 · 28 citations · 48 references
MedicineBiotechnologyImmunologyCell TherapyRegenerative MedicineStem Cell TransplantationCell DeliveryHepatic NecrosisHepatocellular NecrosisLiver RegenerationLiver TransplantationMesenchymal Stem Cell TherapyAcute Hepatic FailureAdipose Stem CellsAdipose-derived Mesenchymal Stem CellsAdipose-derived Mesenchymal Stromal CellsImmunomodulatory EffectsInflammatory Liver InjuryStem Cell-based TherapyTransplantation
BACKGROUND: Systemic inflammatory response syndrome (SIRS) is common in severe fulminant hepatic failure (FHF) and has a high mortality rate (20-50%) due to irreversible cerebral edema or sepsis. Stem cell-based treatment has emerged as a promising alternative therapeutic strategy to prolong the survival of patients suffering from FHF via the inhibition of SIRS due to their immunomodulatory effects. METHODS: 3D spheroids of adipose-derived mesenchymal stem cells (3D-ADSC) were prepared by the hanging drop method. The efficacy of the 3D-ADSC to rescue FHF was evaluated in a D-galactosamine/lipopolysaccharide (GalN/LPS)-induced mouse model of FHF via intraportal transplantation of the spheroids. RESULTS: Intraportally delivered 3D-ADSC better engrafted and localized into the damaged livers compared to 2D-cultured adipose-derived mesenchymal stem cells (2D-ADSC). Transplantation of 3D-ADSC rescued 50% of mice from FHF-induced lethality, whereas only 20% of mice survived when 2D-ADSC were transplanted. The improved transplantation outcomes correlated with the enhanced immunomodulatory effect of 3D-ADSC in the liver microenvironment. CONCLUSION: The study shows that the transplantation of optimized 3D-ADSC can efficiently ameliorate GalN/LPS-induced FHF due to improved viability, resistance to exogenous ROS, and enhanced immunomodulatory effects of 3D-ADSC.
48
Jieli Chen, Yi Li, Lei Wang et al. · Stroke · 2001 · 1.8K citations · Full text
Medicine, Neurobiology, Neuroscience +17
Systemic Delivery of Bone Marrow–Derived Mesenchymal Stem Cells to the Infarcted Myocardium
Israel M. Barbash, Pierre Chouraqui, Jack Baron et al. · Circulation · 2003 · 1.2K citations
Pharmacy, Cardiology, Cell Biology +16